Haleon (HLN) Current Assets (2021 - 2025)
Haleon (HLN) posted Current Assets of $6.1 billion for Q4 2025, down 17.53% on a QoQ basis from $7.3 billion in Q4 2024, and down 17.53% year-over-year from $7.3 billion in Q4 2024.
Haleon (HLN) Current Assets (2021 - 2025) Analysis & Trends
Haleon's Current Assets history runs 5 years deep, the most recent figure standing at $6.1 billion for Q4 2025.
- Quarterly Current Assets fell 17.53% year-over-year to $6.1 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.1 billion (down 17.53% YoY) and the FY2025 annual result came in at $6.0 billion, down 17.92% from the prior year.
- Current Assets was $6.1 billion for Q4 2025 at Haleon, down from $7.3 billion in the prior quarter.
- Across five years, Current Assets topped out at $18.1 billion in Q2 2022 and bottomed at $4.8 billion in Q4 2022.
- A 5-year average of $7.6 billion and a median of $6.0 billion in 2023 frame the typical range for Current Assets.
- Peak annual rise in Current Assets reached 25.6% in 2023, while the deepest fall reached 71.0% in 2023.
- Haleon's Current Assets stood at $7.1 billion in 2021, then plunged by 32.74% to $4.8 billion in 2022, then rose by 25.6% to $6.0 billion in 2023, then climbed by 22.73% to $7.3 billion in 2024, then fell by 17.53% to $6.1 billion in 2025.
- Business Quant data shows HLN's Current Assets at $6.1 billion in Q4 2025, $7.3 billion in Q4 2024, and $5.9 billion in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 258.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.05 Bn |
| Dec 31, 2024 | 7.34 Bn |
| Jun 30, 2024 | 5.95 Bn |
| Dec 31, 2023 | 5.98 Bn |
| Jun 30, 2023 | 5.26 Bn |
| Dec 31, 2022 | 4.76 Bn |
| Jun 30, 2022 | 18.13 Bn |
| Dec 31, 2021 | 7.08 Bn |